A plenary session at the 2020 GRAPPA Annual Meeting was focused on the perspectives of the management of psoriasis and psoriatic arthritis during the COVID-19 pandemic.
The researchers’ goals were to evaluate the geographic differences of opioid administration and to examine how opioid administration was associated with respiratory depression.
Headache may be an early symptom of COVID-19, and identifying patients with characteristic features may help provide early isolation and treatment.
The Infectious Diseases Society of America, American Academy of Neurology, and American College of Rheumatology provided new clinical practice guidelines for Lyme disease prevention, diagnosis, and treatment.
Researchers compared the effect of psoriatic arthritis and rheumatoid arthritis on objective and subjective parameters of hand function.
Researchers assessed the risk for osteoarthritis in patients with PsA compared with those with psoriasis and the general population.
Restrictions on intravenous opioid products at an academic medical institution during a critical drug shortage were not found to have significant impact on overall institutional opioid utilization.
In this observational study, researchers assessed the association between psoriasis, psoriatic arthritis, and osteoporosis.
A targeted program that allows all prescribers to access real-time data and track and compare their own performance with those of others can improve compliance with opioid prescribing guidelines.
Formulation of purified cannabidiol may offer patients with tuberous sclerosis complex a new treatment option for seizures.
